Literature DB >> 23538629

Outcomes of treatment of fungal keratitis at the University of Iowa Hospitals and Clinics: a 10-year retrospective analysis.

Gina M Rogers1, Kenneth M Goins, John E Sutphin, Anna S Kitzmann, Michael D Wagoner.   

Abstract

PURPOSE: To evaluate the outcomes of medical and surgical management of fungal keratitis at a tertiary care eye center.
METHODS: A retrospective review was performed of the medical records of all patients with a diagnosis of microbiologically or histopathologically confirmed fungal keratitis at the University of Iowa Hospitals and Clinics from July 1, 2001, through June 30, 2011. The main outcome measure was a microbiological cure with either medical therapy alone or medical therapy combined with therapeutic keratoplasty (TKP). The secondary outcome measures were graft survival of the TKPs and subsequent optical keratoplasties (OKPs) and visual outcome.
RESULTS: Seventy-three eyes met the inclusion criteria. A microbiological cure was achieved in 72 eyes (98.6%). Forty-one eyes (56.2%) were treated with medical therapy alone, and 32 (43.8%) eyes required 1 TKP (29 eyes) or 2 TKPs (3 eyes). Among the 32 eyes treated with TKP, 17 (53.1%) maintained a clear graft. Among 15 eyes with failed grafts, 12 eyes ultimately achieved clear grafts after a total of 19 OKP procedures. Among 41 eyes treated with medical therapy alone, all 3 eyes treated with OKP remained clear. The final median best-corrected visual acuity was 20/30 in the medical therapy group and 20/40 in the TKP group.
CONCLUSIONS: A high microbiological cure rate can be achieved in eyes with fungal keratitis; however, TKP is often needed to achieve this objective. A good final visual outcome can be achieved in most cases, but multiple keratoplasty procedures may be required.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23538629     DOI: 10.1097/ICO.0b013e3182883e9d

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  11 in total

1.  [The German keratomycosis registry : Initial results of a multicenter survey].

Authors:  M Roth; L Daas; A Renner-Wilde; N Cvetkova-Fischer; M Saeger; M Herwig-Carl; M Matthaei; A Fekete; V Kakkassery; G Walther; M von Lilienfeld-Toal; C Mertens; J Lenk; J Mehlan; C Fischer; M Fuest; S Kroll; W Bayoudh; A Viestenz; A Frings; C R MacKenzie; E M Messmer; B Seitz; O Kurzai; G Geerling
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

2.  Fungal keratitis in the Republic of Ireland.

Authors:  S Farrell; E McElnea; S Moran; S Knowles; C C Murphy
Journal:  Eye (Lond)       Date:  2017-05-19       Impact factor: 3.775

3.  Clinical and Mycological Features of Fungal Keratitis: A Retrospective Single-Center Study (2012-2018)

Authors:  İbrahim İnan Harbiyeli; Elif Erdem; Nuhkan Görkemli; Astan İbayev; Hazal Kandemir; Arbil Açıkalın; Macit İlkit; Meltem Yağmur
Journal:  Turk J Ophthalmol       Date:  2022-04-28

4.  Microbiological profiles of fungal keratitis: a 10-year study at a tertiary referral center.

Authors:  Joanne W Ho; Mark M Fernandez; Rachelle A Rebong; Alan N Carlson; Terry Kim; Natalie A Afshari
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-02-20

5.  A rare case of Phialemonium obovatum keratitis.

Authors:  Emma C Davies; Mary K Daly; Donna Siracuse-Lee
Journal:  Am J Ophthalmol Case Rep       Date:  2016-12-07

6.  Keratomycosis in captive red pandas (Ailurus fulgens): 2 cases.

Authors:  Hayley August Volk; Anu O'Reilly; Kate Bodley; Helen McCracken
Journal:  Open Vet J       Date:  2018-06-01

7.  Outcome of therapeutic penetrating keratoplasty in advanced infectious keratitis.

Authors:  Anuradha Raj; Harsh Bahadur; Renu Dhasmana
Journal:  J Curr Ophthalmol       Date:  2018-04-26

8.  Incidence of recurrent fungal keratitis after primary keratoplasty and visual outcome and prognosis after intervention for the recurrence.

Authors:  Yuerong Gong; Meng Xin
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

9.  Outcomes of therapeutic penetrating keratoplasty in 198 eyes with fungal keratitis.

Authors:  Jyothi Mundra; Rohit Dhakal; Ashik Mohamed; Govinda Jha; Joveeta Joseph; Sunita Chaurasia; Somasheila Murthy
Journal:  Indian J Ophthalmol       Date:  2019-10       Impact factor: 1.848

10.  Rabbit Fungal Keratitis Model of Fusarium solani Tested Against Three Commercially Available Antifungal Drugs.

Authors:  Thet Tun Aung; Wei Hong Jeff Chor; Myoe Naing Lynn; Anita Sook Yee Chan; Donald T H Tan; Roger W Beuerman
Journal:  Eye Contact Lens       Date:  2020-09       Impact factor: 3.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.